Keep up to Date and Stay Informed

Sign up for email alerts to receive company updates including press releases, filings and special announcements straight to your inbox.

Sign me up for:

Latest Financial Results

Q2 2018

Quarter Ended Jun 30, 2018

Latest Annual Filing

Fiscal Year Ended Dec 31, 2017

View Filing

Stock Information

Company Overview

Natus is a leading provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of common medical ailments in neurological dysfunction, epilepsy, sleep disorders, newborn care, hearing impairment and balance and mobility disorders.

Leadership

Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

Natus Medical Incorporated
6701 Koll Center Parkway
Suite 120
Pleasanton, CA 94566
T: 800-645-3616
F: 650-802-0401

Investor Relations

Natus Medical Incorporated
Sharon R. Villaverde
Interim Chief Financial Officer
T: (925) 223-6700
InvestorRelations@Natus.com

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, NY 11717
T: (877) 830-4936
www.shareholder.broadridge.com

Market Data copyright © 2018 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.